Thorne, a DTC supplement brand built on personalization and science-backed formulations, was acquired by Procter & Gamble for $3.8 billion, signaling major interest in proprietary DTC health platforms.
ReadingThe steal: the exit price telegraphs what P&G values: brands with proprietary customer data systems and personalization engines outrank commodity brands. For a smaller player, this means: build a moat that is not SKU scarcity or paid ads. Build a system that only you can run. If you sell supplements, skin care, fitness gear, or anything health-adjacent, the pattern is obvious: collect customer data (health history, preferences, goals), personalize the product or recommendation, and make repeat purchase the default. The customer is now sticky because the product is for them, not for everyone. That is the architecture that attracts acquirers and outlasts competitors.
MY STASH TAKEThorne built something rare in CPG: a reason for customers to come back that was not 'lower price' or 'free shipping.' It was 'this was made for me.' That kind of stickiness is what P&G wanted to own. Any brand thinking about a future exit or just trying to stay ahead of bigger competitors should study Thorne's move: make the customer data valuable by using it to make products that only work for that customer. Everything else is replaceable.
WatchWatch for P&G to integrate Thorne's personalization platform into existing health and beauty categories, expanding the model across the portfolio.